Concepedia

Liang Zhu

LZ

Statistics

Publications

23

Citations

873

H-Index

17

Active since

1992

Affiliations

Second Xiangya Hospital of Central South University(Current)

Central South University

Huazhong University of Science and Technology

Union Hospital

Wuhan Union Hospital

Liang Zhu is an author at Second Xiangya Hospital of Central South University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1992–2025

23

Publications

23

RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway

Wei Xiong, Bin Zhang, Haixin Yu et al. · Advanced Science · 2021 · 170 citations · Full text

, , +17

ZDHHC2-Mediated AGK Palmitoylation Activates AKT–mTOR Signaling to Reduce Sunitinib Sensitivity in Renal Cell Carcinoma

Yan Sun, Liang Zhu, Pian Liu et al. · Cancer Research · 2023 · 78 citations · Full text

, , +17

YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway

Wei Li, Kun Ye, Xurui Li et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 71 citations · Full text

, , +17

OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIs

Wentao Liu, Bin Yan, Haixin Yu et al. · International Journal of Biological Sciences · 2022 · 66 citations · Full text

, , +17

Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway

Wei Xiong, Changkun Huang, Huanghao Deng et al. · The International Journal of Biochemistry & Cell Biology · 2017 · 63 citations

, , +16

1–5 of 23